GENEVA, Oct. 27 -- ASTRAZENECA AB (SE-151-85Sodertalje) filed a patent application (PCT/IB2025/054074) for "THIO-SUBSTITUTED 1,3,5-TRIAZINE CX3CR1 MODULATORS" on Apr 17, 2025. With publication no. WO/2025/219947, the details related to the patent application was published on Oct 23, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): NILSSON, Karolina (c/o AstraZeneca ABSE-151 85Sodertalje), BRINK, Mikael (c/o AstraZeneca ABSE151-85Sodertalje), PAHLEN, Sara (c/o AstraZeneca ABSE1151-85Sodertalje)
Abstract: The present disclosure provides thio-substituted 1,3,5-triazine CX3CR1 modulators, pharma...